Format
Sort by
Items per page

Send to

Choose Destination

Best matches for adverse drug reaction:

Severe cutaneous adverse reactions to drugs. Duong TA et al. Lancet. (2017)

Adverse drug reactions. Seagrave Z et al. Dis Mon. (2017)

Adverse Drug Reactions: Type A (Intrinsic) or Type B (Idiosyncratic). Iasella CJ et al. Clin Liver Dis. (2017)

Search results

Items: 1 to 20 of 141192

1.

Naltrexone-associated Visual Hallucinations: A Case Report.

Lee DB, Woo YS, Bahk WM.

Clin Psychopharmacol Neurosci. 2019 May 31;17(2):329-331. doi: 10.9758/cpn.2019.17.2.329.

PMID:
30905136
2.

Musical Hallucination Caused by Ceftazidime in a Woman with a Hearing Impairment.

Song CI, Jung YE.

Clin Psychopharmacol Neurosci. 2019 May 31;17(2):326-328. doi: 10.9758/cpn.2019.17.2.326.

PMID:
30905135
3.

Efficacy and Safety of Octagam® in Patients With Chronic Inflammatory Demyelinating Polyneuropathy.

Belmokhtar C, Lozeron P, Adams D, Franques J, Lacour A, Godet E, Bataille M, Dubourg O, Angibaud G, Delmont E, Bouhour F, Corcia P, Pouget J.

Neurol Ther. 2019 Mar 22. doi: 10.1007/s40120-019-0132-5. [Epub ahead of print]

PMID:
30903535
4.

Evaluating Penicillin Allergies Without Skin Testing.

Banks TA, Tucker M, Macy E.

Curr Allergy Asthma Rep. 2019 Mar 22;19(5):27. doi: 10.1007/s11882-019-0854-6. Review.

PMID:
30903298
5.

Cutaneous Toxicity after Chemoradiotherapy and PD-L1 Inhibition in Two Patients with Esophageal Adenocarcinoma: More than Meets the Eye.

van den Ende T, Menting SP, Ambarus CA, van Oijen MGH, van Laarhoven HWM.

Oncologist. 2019 Mar 22. pii: theoncologist.2018-0674. doi: 10.1634/theoncologist.2018-0674. [Epub ahead of print]

PMID:
30902915
6.

[Impact of therapeutic advice on prescription of psychotropics for patients with serious mental illness].

Lebas E, Clerc B, Mangavelle J, Megard R, Franck N.

Encephale. 2019 Mar 19. pii: S0013-7006(19)30037-5. doi: 10.1016/j.encep.2018.11.006. [Epub ahead of print] French.

PMID:
30902340
7.

Kounis syndrome: A retrospective analysis of individual case safety reports from the international WHO database in pharmacovigilance
.

Orion K, Mack J, Kullak-Ublick GA, Weiler S.

Int J Clin Pharmacol Ther. 2019 Mar 22. doi: 10.5414/CP203344. [Epub ahead of print]

PMID:
30900982
8.

Searching for analgesic drug candidates alleviating oxaliplatin-induced cold hypersensitivity in mice.

Sałat K, Furgała A, Malikowska-Racia N.

Chem Biol Drug Des. 2019 Mar 22. doi: 10.1111/cbdd.13507. [Epub ahead of print]

PMID:
30900821
9.

Adverse Reactions to Medications: Concept Analysis and Development of a New Risk Nursing Diagnosis.

Monteiro Mantovani V, Moorhead S, de Abreu Almeida M, Rabelo-Silva ER.

Int J Nurs Knowl. 2019 Mar 21. doi: 10.1111/2047-3095.12237. [Epub ahead of print]

PMID:
30900386
10.

Retrospective study of irrational prescribing in French paediatric hospital: prevalence of inappropriate prescription detected by Pediatrics: Omission of Prescription and Inappropriate prescription (POPI) in the emergency unit and in the ambulatory setting.

Berthe-Aucejo A, Nguyen PKH, Angoulvant F, Bellettre X, Albaret P, Weil T, Boulkedid R, Bourdon O, Prot-Labarthe S.

BMJ Open. 2019 Mar 20;9(3):e019186. doi: 10.1136/bmjopen-2017-019186.

11.

Adverse events in patients with high platelet reactivity following successful chronic total occlusion PCI: The Assessment of Dual AntiPlatelet Therapy with Drug-Eluting Stents (ADAPT-DES) study.

Finn MT, Redfors B, Karmpaliotis D, Kirtane AJ, Green P, McAndrew T, Liu M, Cloney MB, Witzenbichler B, Weisz G, Stuckey TD, Brodie BR, Rinaldi MJ, Neumann FJ, Metzger DC, Henry TD, Cox DA, Duffy PL, Mazzaferri EL Jr, Mehran R, Stone GW.

Am Heart J. 2019 Feb 20;211:68-76. doi: 10.1016/j.ahj.2019.02.002. [Epub ahead of print]

PMID:
30897527
12.

HLA associated antiepileptic drug-induced cutaneous adverse reactions.

Mullan KA, Anderson A, Illing PT, Kwan P, Purcell AW, Mifsud NA.

HLA. 2019 Mar 20. doi: 10.1111/tan.13530. [Epub ahead of print] Review.

PMID:
30895730
13.

Skin test of tuberculin purified protein derivatives with a dissolving microneedle-array patch.

Wang W, Liu HM, Zhou J, Wang YG, Feng X, Tang H, Yan Q, Zhu RS, Wu YW, Wang XG, He D, Chen F.

Drug Deliv Transl Res. 2019 Mar 19. doi: 10.1007/s13346-019-00629-y. [Epub ahead of print]

PMID:
30891708
14.

Ustekinumab-induced subacute cutaneous lupus.

Tierney E, Kirthi S, Ramsay B, Ahmad K.

JAAD Case Rep. 2019 Mar 1;5(3):271-273. doi: 10.1016/j.jdcr.2019.01.015. eCollection 2019 Mar. No abstract available.

15.

Flexible two-layer dissolving and safing Microneedle transdermal of Neurotoxin: A biocomfortable attempt to treat Rheumatoid Arthritis.

Yao W, Tao C, Zou J, Zheng H, Zhu J, Zhu Z, Zhu J, Liu L, Li F, Song X.

Int J Pharm. 2019 Mar 16. pii: S0378-5173(19)30219-4. doi: 10.1016/j.ijpharm.2019.03.033. [Epub ahead of print]

PMID:
30890451
16.

Topical Fisionerv® is effective in treatment of peripheral neuropathic pain.

Tarullo A, Tarullo A, Lacatena E, Santacroce L, Inchingolo AM, Malcangi G, Scacco S, Fanelli M, Cagiano R, Inchingolo F, Caprio M, Dipalma G, Ballini A, Clemente A, Inchingolo AD, Girolamo F, Tattoli M.

Acta Biomed. 2019 Jan 24;90(1):51-55. doi: 10.23750/abm.v90i1.6305.

PMID:
30889155
17.

Drug-Induced Photosensitivity-An Update: Culprit Drugs, Prevention and Management.

Blakely KM, Drucker AM, Rosen CF.

Drug Saf. 2019 Mar 19. doi: 10.1007/s40264-019-00806-5. [Epub ahead of print] Review.

PMID:
30888626
18.

Adverse event profiles of solvent-based and nanoparticle albumin-bound paclitaxel formulations using the Food and Drug Administration Adverse Event Reporting System.

Naganuma M, Tahara K, Hasegawa S, Fukuda A, Sasaoka S, Hatahira H, Motooka Y, Nakao S, Mukai R, Hirade K, Yoshimura T, Kato T, Takeuchi H, Nakamura M.

SAGE Open Med. 2019 Mar 11;7:2050312119836011. doi: 10.1177/2050312119836011. eCollection 2019.

19.

Dynamics of Organic Anion Transporter-Mediated Tubular Secretion during Postnatal Human Kidney Development and Maturation.

Momper JD, Yang J, Gockenbach M, Vaida F, Nigam SK.

Clin J Am Soc Nephrol. 2019 Mar 18. pii: CJN.10350818. doi: 10.2215/CJN.10350818. [Epub ahead of print]

PMID:
30885911
20.

"Rituximab hypersensitivity and desensitization: A personalized approach to treat cancer and connective tissue diseases".

Yang BC, Castells MC.

Ann Allergy Asthma Immunol. 2019 Mar 15. pii: S1081-1206(19)30187-5. doi: 10.1016/j.anai.2019.03.008. [Epub ahead of print] No abstract available.

PMID:
30885801

Supplemental Content

Loading ...
Support Center